Share prices for Follicum (FOLLI)

Price information

Orders

Deals

Video

Scheduled Reports

Interim Report Q1

Annual General Meeting

Half Year Report

Interim Report Q3

Year End Report

About company

Follicum is a biotech company focused on the discovery and development of peptide-based drugs. The primary focus is in hair growth stimulation, where Follicum has obtained very promising results with FOL-005 in a recently completed clinical trial. In diabetes, the drug candidate FOL-014 has demonstrated an increase in insulin release in pre-clinical models. The company was founded in 2011, and is based in Lund, Sweden. Follicum is listed on the Swedish small cap exchange Aktietorget since 2014. www.follicum.com.

  • CEO Jan Alenfall
  • Chairm. of the Board Fredrik Buch

Instrument Information

  • Full Name Follicum
  • Short Name FOLLI
  • No of shares 28 121 566
  • ISIN code SE0006288270
  • OrderBookID 412P
  • CFI (ISO 10962) ESVUFR
  • FISN (ISO 18774) FOLLICUMAB/SH
  • Liquidity Provider Sedermera Fondkommission
  • Par Value 0.12 kr
  • First Traded 25-11-2014
  • Type Share

Contact